Abstract
To evaluate the safety and efficacy of ziv-aflibercept (Zaltrap; Sanofi-Aventis, Bridgewater, NJ/Regeneron Pharmaceuticals, Tarrytown, NY) in the treatment of refractory diabetic macular edema (DME). Retrospective case series looking at the safety of ziv-aflibercept in patients with DME refractory to previous anti-vascular endothelial growth factor (VEGF) therapy. Detailed ophthalmologic examination, best-corrected visual acuity, and optical coherence tomography measurements were performed pre-switch, as well as at each monthly follow-up visit. The study included 34 eyes of 26 patients. The mean number of ziv-aflibercept injections post-switch was 2.03 injections. Visual acuity improved from a mean of 0.63 logMAR pre-switch to 0.51 logMAR after the first visit and 0.46 logMAR after the second visit post-switch (P < .084). Macular thickness improved from a mean of 513.79 μm to 411.79 μm (P = .006) on the first visit and 426.76 μm (P = .029) after the second visit post-switch. No adverse ocular or systemic side effects were reported on any of the follow visits. Ziv-aflibercept appears to be safe and effective in patients with refractory DME previously treated with other anti-VEGF agents in the short term. [Ophthalmic Surg Lasers ...Continue Reading
References
Aug 28, 2003·Diabetes Care·Thomas A CiullaBernard Zinman
Apr 5, 2011·Ophthalmology·Paul MitchellUNKNOWN RESTORE study group
May 20, 2014·The British Journal of Ophthalmology·Deepika MalikBaruch D Kuppermann
Jul 12, 2014·Ophthalmology·Jean-François KorobelnikDavid M Brown
Dec 3, 2014·Ophthalmology·Michael J ElmanUNKNOWN Diabetic Retinopathy Clinical Research Network
Jan 7, 2015·Ophthalmic Surgery, Lasers & Imaging Retina·João Rafael de Oliveira DiasEduardo Büchele Rodrigues
Jan 21, 2015·Ophthalmology·Amitha DomalpallyJason S Ehrlich
Jan 31, 2015·Eye·D S DhootR L Avery
Feb 14, 2015·The British Journal of Ophthalmology·Ahmad M MansourMarwan E El-Sabban
Feb 19, 2015·The New England Journal of Medicine·UNKNOWN Diabetic Retinopathy Clinical Research NetworkRoy W Beck
Mar 25, 2015·Case Reports in Ophthalmology·Joel Hanhart, Itay Chowers
Jul 4, 2015·Indian Journal of Ophthalmology·Jay Chhablani
Jul 23, 2015·Ophthalmology·David M BrownJean-François Korobelnik
Dec 15, 2015·Retina·Jay ChhablaniMichael Stewart
Mar 19, 2016·Retina·Gabriel Costa de AndradeEduardo Büchele Rodrigues
May 18, 2016·The British Journal of Ophthalmology·Ahmad M MansourJay Chhablani
Oct 19, 2016·Acta Ophthalmologica·Mohammed AshrafMohamed Hossam Abdallah
Citations
Oct 4, 2017·Asia-Pacific Journal of Ophthalmology·Sumit Randhir SinghJay Chhablani
Jan 11, 2018·The British Journal of Ophthalmology·Ahmad M MansourUNKNOWN Ziv-aflibercept study group investigators
Mar 8, 2019·European Journal of Ophthalmology·Sergio E Hernandez-Da MotaErnesto Rodríguez-Ayala
Jul 18, 2019·Seminars in Ophthalmology·Daniel Barmas-AlamdariAlan L Wagner
Aug 25, 2017·Current Opinion in Ophthalmology·Sophie Cai, Neil M Bressler
Dec 22, 2019·Acta Ophthalmologica·Ahmad M MansourJay Chhablani
Nov 6, 2018·International Journal of Retina and Vitreous·Julia de Lima FarahMichel Eid Farah
Mar 27, 2020·Ophthalmic Surgery, Lasers & Imaging Retina·Nazanin EbrahimiadibMohammad Riazi-Esfahani
Sep 6, 2020·Journal of Ethnopharmacology·Hui-Hui SunJing Han